哈洛佩里多尔在治疗妄症,降低死亡率和预防妄症的发生方面:贝叶斯式和频率主义的元分析
Shu-Li Cheng1, Tien-Wei Hsu2,3,4,5, Yu-Chen Kao6,7
1Department of Nursing, Mackay Medical College, Taipei, Taiwan.
Critical care (London, England)
|March 21, 2025
概括
哈洛佩里多尔有效地治疗了重症监护室 (ICU) 患者的痴呆症,降低了死亡率和二胺的使用. 然而,由于不确的证据和潜在的风险,不建议在ICU环境中预防妄想.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 痴呆症是重症监护室 (ICU) 患者常见的并发症.
- 皮醇经常用于妄治疗,但其有效性和安全性仍在争论中.
- 需要强有力的证据来指导在ICU Delirium中使用Haloperidol.
研究的目的:
- 综合评估哈洛佩里多尔在成人ICU患者治疗和预防痴呆的疗效和安全性.
- 通过频率主义和贝叶斯分析,综合随机对照试验 (RCT) 的证据.
- 确定关键结果临床重要益处或危害的概率.
主要方法:
- 在多个数据库 (MEDLINE,Embase,Cochrane,ClinicalTrials.gov,PubMed) 进行系统搜索,截至2024年6月.
- 纳入双盲随机对照试验 (RCT),将成年ICU患者的哈洛佩里多尔与安慰剂进行比较.
- 主要结局包括死亡率,严重不良事件 (SAE) 和事件妄想;次要结局评估了没有妄想或昏迷的天数,QTc延长和额外金字塔综合征.
主要成果:
- 对于治疗狂妄症,哈洛佩里多尔在降低死亡率方面显示出68%的临床重要益处的概率和78%的减少救援二甲使用的概率.
- 在大多数治疗安全结果中,哈洛佩里多尔造成临床重要伤害的概率很低 (<50%).
- 对于预防狂妄症,哈洛佩里多尔在疗效结果中具有临床重要益处的概率低 (<50%),并且导致QTc延长的概率为65%.
结论:
- 证据支持使用利治疗成年ICU患者的痴呆症.
- 根据目前的证据,Haloperidol不推用于预防成年ICU患者的痴呆症.
- 可能需要进一步的研究来澄清最佳使用和安全概况.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
101
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
101
01:28Psychosis and Antipsychotic Drugs: Overview
167
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
167
01:28Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
111
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
111
01:22Alzheimer's Disease: Treatment
139
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
139
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
138
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
138